Increasingly, pharmaceutical companies and organizations conducting research to push cancer into history are realizing that the answer may lie in big data and in sharing it. To achieve this they need reliable network infrastructure that isn’t slowed down by the data and network latency. Even with the ever growing volumes of big data, it’s important to allow data to flow fast to permit accurate analysis.
On 27th April 2017, The Telegraph newspaper wrote: “How data is helping to select the best new cancer treatments for patients”. The article, sponsored by Cancer Research UK, revealed: “Gifts left in wills help Dr. Bissan Al-Azikani and her team to look at vast amounts of data, which can aid them in identifying the best new cancer treatments for patients”.
Talking about her role, Dr. Bissan Al-Azikani commented: “In the past 10 years, we have made huge strides in discovering therapies as a result of understanding cancer at a molecular level. The challenge is to decide which cancer drug targets show the most promise and they should be prioritised for development. We use artificial intelligence to select the best drug targets by combining DNA data from tens of thousands of patients with billions of results from lab experiments.”
Find more about how faster data could speed up the process to find a cure for cancer.
Published by Pharmaceutical Executive on 17th July 2017. By-lined to David Trossell is CEO and CTO of Bridgeworks. #YearInReview
Recent Comments